A Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Melanoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a safety and efficacy study of different administration regimens of nivolumab plus Ipilimumab in subjects with previously untreated, unresectable or metastatic melanoma.
Epistemonikos ID: bc7591d4967dca667336583cdb6237b1128d23be
First added on: May 17, 2024